Literature DB >> 10735331

The impact of clinically diagnosed personality disorders on acute and one-year outcomes of electroconvulsive therapy.

J Sareen1, M W Enns, J E Guertin.   

Abstract

Clinical experience suggests that patients with depression and a comorbid personality disorder (PD) may have a poorer response to electroconvulsive therapy (ECT). Only a few published studies have examined the relationship between comorbid personality disorders and response of major depression to ECT. These studies have used relatively small numbers of patients. The present study is a retrospective review of 107 inpatients with a major depressive episode referred for ECT. Patients with a clinically diagnosed PD, especially a cluster B PD, had a significantly poorer acute response to ECT than those without a PD. During the first year after treatment, ECT responders with a comorbid PD had a higher rate of relapse of depression. The retrospective study design limits the strength of conclusions that can be drawn. Nevertheless, it appears that clinically diagnosed PDs may be predictive of poor outcome in patients receiving ECT for depression. Further prospective study of the relationship between both clinically diagnosed PDs and structured interview based PD diagnoses and ECT treatment response is warranted.

Entities:  

Mesh:

Year:  2000        PMID: 10735331     DOI: 10.1097/00124509-200003000-00006

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  3 in total

Review 1.  Electroconvulsive therapy: Part II: a biopsychosocial perspective.

Authors:  Nancy A Payne; Joan Prudic
Journal:  J Psychiatr Pract       Date:  2009-09       Impact factor: 1.325

2.  Role of Electroconvulsive Therapy in Major Depressive Disorder with Borderline Personality Disorder: Case Report and Literature Review.

Authors:  Saad Wasiq; Ahmad R Khan; Amber E Faquih; Hina Saeed; Hafsa Mahmood
Journal:  Cureus       Date:  2018-08-27

3.  Predictors of the short-term responder rate of Electroconvulsive therapy in depressive disorders--a population based study.

Authors:  Axel Nordenskjöld; Lars von Knorring; Ingemar Engström
Journal:  BMC Psychiatry       Date:  2012-08-17       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.